Puromycin aminonucleoside
- Level
- Commodity
- Parent
- 51281900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281912This classification denotes a protein synthesis inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula C12H18N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Q580U88V8, chemically known as 6-(dimethylamino)-9-(3-amino-3-deoxy-.beta.-d-ribofuranosyl)purine, but more generally known as puromycin aminonucleoside, which bears US NIH Compound Identifier 1599. European Medicines Agency schedules puromycin aminonucleoside or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10161MIG. Most nations, for tariff purposes, schedule puromycin aminonucleoside under HS 29419000. SMILES: CN(C)C1C2C(NCN1)N(CN2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)N)O.
Same parent
Under 51281900 · 12Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.